The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting

Affiliations

• ¹ From the Advisory Services, IQVIA, Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina; International Dermatology Outcome Measurers, Windsor, Connecticut; Johns Hopkins University School of Medicine, Center for Child and Community Health Research, Baltimore, Maryland; Cleveland Clinic, Cleveland, Ohio, USA; Our Lady's Hospice and Care Services, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands; Biomedical Laboratory Scientist, Oslo University Hospital, Oslo, Norway; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; Toronto Western Hospital, Psoriatic Arthritis Clinic, Toronto, Ontario, Canada. [email protected].
• ² N. Goel, MD, Patient Research Partner, Vice President, Advisory Services, IQVIA, Adjunct Assistant Professor, Duke University School of Medicine; D. O'Sullivan, BE, Patient Research Partner, Our Lady's Hospice and Care Services; M. de Wit, PhD, Patient Research Partner, Department of Medical Humanities, VU University Medical Centre; C.A. Lindsay, PharmD, Patient Research Partner; H. Bertheussen, Cand.mag, Patient Research Partner, Biomedical Laboratory Scientist, Oslo University Hospital; J. Latella, BS, MS, Patient Research Partner, and Board Member, International Dermatology Outcome Measurers; J. Chau, BA, MCS, Patient Research Partner, Hong Kong Psoriatic Arthritis Association; R. MacDonald, Patient Research Partner, Toronto Western Hospital, Psoriatic Arthritis Clinic; S. Grieb, PhD, MSPH, Patient Research Partner, Johns Hopkins University School of Medicine, Center for Child and Community Health Research; I. Steinkoenig, BA, Patient Research Partner, Cleveland Clinic; W. Campbell, BEd LLB, Patient Research Partner, Toronto Western Hospital, Psoriatic Arthritis Clinic. [email protected].
• ³ From the Advisory Services, IQVIA, Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina; International Dermatology Outcome Measurers, Windsor, Connecticut; Johns Hopkins University School of Medicine, Center for Child and Community Health Research, Baltimore, Maryland; Cleveland Clinic, Cleveland, Ohio, USA; Our Lady's Hospice and Care Services, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands; Biomedical Laboratory Scientist, Oslo University Hospital, Oslo, Norway; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; Toronto Western Hospital, Psoriatic Arthritis Clinic, Toronto, Ontario, Canada.
• ⁴ N. Goel, MD, Patient Research Partner, Vice President, Advisory Services, IQVIA, Adjunct Assistant Professor, Duke University School of Medicine; D. O'Sullivan, BE, Patient Research Partner, Our Lady's Hospice and Care Services; M. de Wit, PhD, Patient Research Partner, Department of Medical Humanities, VU University Medical Centre; C.A. Lindsay, PharmD, Patient Research Partner; H. Bertheussen, Cand.mag, Patient Research Partner, Biomedical Laboratory Scientist, Oslo University Hospital; J. Latella, BS, MS, Patient Research Partner, and Board Member, International Dermatology Outcome Measurers; J. Chau, BA, MCS, Patient Research Partner, Hong Kong Psoriatic Arthritis Association; R. MacDonald, Patient Research Partner, Toronto Western Hospital, Psoriatic Arthritis Clinic; S. Grieb, PhD, MSPH, Patient Research Partner, Johns Hopkins University School of Medicine, Center for Child and Community Health Research; I. Steinkoenig, BA, Patient Research Partner, Cleveland Clinic; W. Campbell, BEd LLB, Patient Research Partner, Toronto Western Hospital, Psoriatic Arthritis Clinic.